DRW Securities’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$490K Buy
969
+506
+109% +$284K 0.01% 438
2026
Q1
$257K Buy
+463
New +$297K ﹤0.01% 979
2025
Q3
– Sell
-611
Closed -$328K – 1451
2025
Q2
$328K Buy
+611
New +$292K 0.01% 691
2024
Q2
– Sell
-599
Closed -$323K – 577
2024
Q1
$323K Buy
+599
New +$327K 0.01% 269
2023
Q3
– Sell
-407
Closed -$204K – 399
2023
Q2
$204K Buy
+407
New +$195K 0.01% 302
2021
Q3
– Sell
-348
Closed -$220K – 317
2021
Q2
$220K Buy
+348
New +$192K 0.01% 264

Other funds holding IDXX

DRW Securities's IDXX Position: Q2 2026 in Review

DRW Securities increased its Idexx Laboratories (IDXX) stake by 109% in Q2 2026, buying an estimated $284K and bringing the position to 969 shares worth $490K. The position accounts for 0.01% of the portfolio, ranked #438.

DRW Securities first reported a position in IDXX in Q2 2021 and has held it in 6 quarters since. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • DRW Securities held 969 shares of Idexx Laboratories worth $490K as of Q2 2026.
  • DRW Securities bought 506 Idexx Laboratories shares in Q2 2026, an estimated $284K.
  • Idexx Laboratories made up 0.01% of DRW Securities's portfolio in Q2 2026, its #438 holding.
  • DRW Securities first reported a position in Idexx Laboratories in Q2 2021 and has held it in 6 quarters since.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.